Drugs of abuse testing is performed to screen for and confirm the presence of drugs in a person's sample of urine, blood, breath, saliva or hair. FDA-approved point of care urine drug test cups are now available for use in medical screening, legal or forensic information, employment drug testing, sports or athletics testing, and monitoring pain medication use.
Drug testing allows the individual to be provided with appropriate medical treatment or be screened for or monitored for illegal drug use. Commonly screened drugs include amphetamine and methamphetamine, barbiturates such as phenobarbital, secobarbital and pentobarbital, benzodiazepines such as diazepam, lorazepam and oxazepam, marijuana, cocaine, methadone, opiates, such as heroin, codeine and morphine, and phencyclidine.
The global drugs of abuse testing market report by iHealthcareAnalyst, Inc. provides a detailed picture of market size, market share, forecasts growth trends and geographical area. The report analyzes market opportunities and provides updates and insights pertaining to its various segments:
- Product type - analyzers such as breath analyzers, chromatographic devices, immunoassays analyzers, and rapid testing devices; oral fluid testing devices; urine testing devices; consumables, fluid collection devices and so on.
- Test type - criminal justice testing, pain management testing, work place screening. End users of the market include diagnostics laboratories, forensic laboratories, hospitals and on-site testing.
- Geographically, the market is divided into: North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
The report identifies the key players operating in the market as: Alere, Inc., Drägerwerk AG & Co. KGaA, Express Diagnostics International, Inc., F. Hoffmann La-Roche Ltd, Laboratory Corporation of America Holdings, Shimadzu Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc.
One of the latest products in the field of drugs of abuse screening, the QuikScreen Multi 12 drug test cup is manufactured in the USA. Unlike other on-site tests, QuikScreen® does not require any handling or manipulation to activate the test. It provides accurate results within a few minutes after the urine sample is dispensed into the cup.